Synthesis, Characterization, and Evaluation of Silver Nanoparticle-Loaded Carboxymethyl Chitosan with Sulfobetaine Methacrylate Hydrogel Nanocomposites for Biomedical Applications.

In this study, nanocomposites of AgNPs encapsulated in carboxymethyl chitosan (CMCS) with sulfobetaine methacrylate (SB) hydrogel (AgNPs/CMCS-SB) were synthesized. The UV-Vis spectra indicated the presence of AgNPs, with a broad peak at around 424 nm, while the AgNPs-loaded CMCS-SB nanocomposite exhibited absorption peaks at 445 nm. The size and dispersion of AgNPs varied with the concentration of the AgNO3 solution, affecting swelling rates: 148.37 ± 15.63%, 172.26 ± 18.14%, and 159.17 ± 16.59% for 1.0 mM, 3.0 mM, and 5.0 mM AgNPs/CMCS-SB, respectively. Additionally, water absorption capacity increased with AgNPs content, peaking at 11.04 ± 0.54% for the 3.0 mM AgNPs/CMCS-SB nanocomposite. Silver release from the nanocomposite was influenced by AgNO3 concentration, showing rapid initial release followed by a slower rate over time for the 3.0 mM AgNPs/CMCS-SB. XRD patterns affirmed the presence of AgNPs, showcasing characteristic peaks indicative of a face-centered cubic (fcc) structure. The FTIR spectra highlighted interactions between AgNPs and CMCS-SB, with noticeable shifts in characteristic bands. In addition, SEM and TEM images validated spherical AgNPs within the CMCS-SB hydrogel network, averaging approximately 70 and 30 nm in diameter, respectively. The nanocomposite exhibited significant antibacterial activity against S. aureus and E. coli, with inhibition rates of 98.9 ± 0.21% and 99.2 ± 0.14%, respectively, for the 3.0 mM AgNPs/CMCS-SB nanocomposite. Moreover, cytotoxicity assays showcased the efficacy of AgNPs/CMCS-SB against human colorectal cancer cells (HCT-116 cells), with the strongest cytotoxicity (61.7 ± 4.3%) at 100 µg/mL. These results suggest the synthesized AgNPs/CMCS-SB nanocomposites possess promising attributes for various biomedical applications, including antimicrobial and anticancer activities, positioning them as compelling candidates for further advancement in biomedicine.

Nitrogen and sulfur co-doped photoluminescent carbon dots for highly selective and sensitive detection of Ag+ and Hg2+ ions in aqueous media: Applications in bioimaging and real sample analysis.

In this study, we report the synthesis of photoluminescent (PL) nitrogen (N) and sulfur (S) co-doped carbon dots (NS-CDs) from nitazoxanide and 3-mercaptopropionic acid as a precursors via a one-pot hydrothermal methods. N and S co-doped materials allows more active sites in the CDs surface resulting in an enhancement of their PL properties. NS-CDs show bright blue PL, excellent optical properties, good water solubility, and a high quantum yield (QY) of 32.1%. The as-prepared NS-CDs were confirmed by UV-Visible, photoluminescence, FTIR, XRD and TEM analysis. An optimized excitation at 345 nm, the NS-CDs exhibited strong PL emission at 423 nm with an average size of 3.53 ± 0.25 nm. Under optimized conditions, the NS-CDs PL probe shows high selectivity with Ag+/Hg2+ ions detected, while other cations no significant changes the PL signal. The PL intensity of NS-CDs linearly quenching and enhancement with Ag+ and Hg2+ ions from 0 to 50 × 10-6 M, with the detection limit of 2.15 × 10-6 M and 6.77 × 10-7 M (S/N = 3). More interestingly, as-synthesized NS-CDs shows a strong binding to Ag+/Hg2+ ions with the PL quenching and enhancement to precise and quantitative detection of Ag+/Hg2+ ions in living cells. The proposed system was effectively utilized for the sensing of Ag+/Hg2+ ions in real samples resulting in high sensitivity and good recoveries (98.4-109.7%).

Tenofovir antiviral drug solubility enhancement with ß-cyclodextrin inclusion complex and in silico study of potential inhibitor against SARS-CoV-2 main protease (Mpro).

Tenofovir (TFR) is an antiviral drug commonly used to fight against viral diseases infection due to its good potency and high genetic barrier to drug resistance. In physiological conditions, TFR is less water soluble, more unstable, and less permeable, limiting its effective therapeutic applications. In addition to their use in treating the Coronavirus disease 2019 (COVID-19), cyclodextrins (CDs) are also being used as a molecule to develop therapies for other diseases due to its enhance solubility and stability. This study is designed to synthesize and characterization of ß-CD:TFR inclusion complex and its interaction against SARS-CoV-2 (MPro) protein (PDB ID;7cam). Several techniques were used to characterize the prepared ß-CD:TFR inclusion complex, including UV-Visible, FT-IR, XRD, SEM, TGA, and DSC, which provided appropriate evidence to confirm the formation. A 1:1 stoichiometry was determined for ß-CD:TFR inclusion complex in aqueous medium from UV-Visible absorption spectra by using the Benesi-Hildebrand method. Phase solubility studies proposed that ß-CD enhanced the excellent solubility of TFR and the stability constant was obtained at 863 ± 32 M-1. Moreover, the molecular docking confirmed the experimental results demonstrated the most desirable mode of TFR encapsulated into the ß-CD nanocavity via hydrophobic interactions and possible hydrogen bonds. Moreover, TFR was validated in the ß-CD:TFR inclusion complex as potential inhibitors against SARS-CoV-2 main protease (Mpro) receptors by using in silico methods. The enhanced solubility, stability, and antiviral activity against SARS-CoV-2 (MPro) suggest that ß-CD:TFR inclusion complexes can be further used as feasible water-insoluble antiviral drug carriers in viral disease infection.